Literature DB >> 6468837

Effects of sodium chloride, saccharin, phenobarbital and aspirin on gastric carcinogenesis in rats after initiation with N-methyl-N'-nitro-N-nitrosoguanidine.

M Takahashi, T Kokubo, F Furukawa, Y Kurokawa, Y Hayashi.   

Abstract

Sodium chloride, saccharin sodium, phenobarbital sodium and aspirin were tested for tumor-promoting activity in the glandular stomach of rats after initiation with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) coupled with administration of a high salt diet. Male outbred Wistar rats were given MNNG in the drinking water (100 mg/liter) for 8 weeks, and during this period they were fed on diet supplemented with 10% sodium chloride. Thereafter, they were divided into 5 groups and fed on the basal diet or one of various diets supplemented with 10% sodium chloride, 5% saccharin, 0.05% phenobarbital or 1% aspirin until the end of the experiment. All animals were killed at the 40th experimental week for necropsy and histological examination. The incidence of adenocarcinoma was increased in the group given sodium chloride following initiation by MNNG and sodium chloride as compared with the group given MNNG and sodium chloride initiation only, but not significantly. However, the incidence of preneoplastic hyperplasia was significantly increased in this group. Saccharin also enhanced the development of adenocarcinomas of the glandular stomach. The results indicated that dietary administration of sodium chloride or saccharin after MNNG tends to promote tumor development. Phenobarbital or aspirin did not enhance tumor development, aspirin in fact rather showing a tendency to decrease the tumor incidence.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6468837

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  13 in total

Review 1.  Gastric carcinogenesis: diet as a causative factor.

Authors:  T Sugimura; K Wakabayashi
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

Review 2.  Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.

Authors:  Yun Dai; Wei-Hong Wang
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

3.  Lycopene enhances antioxidant enzyme activities and immunity function in N-methyl-N'-nitro-N-nitrosoguanidine-enduced gastric cancer rats.

Authors:  Cong Luo; Xian-Guo Wu
Journal:  Int J Mol Sci       Date:  2011-05-23       Impact factor: 5.923

Review 4.  Nutrition and stomach cancer.

Authors:  S Kono; T Hirohata
Journal:  Cancer Causes Control       Date:  1996-01       Impact factor: 2.506

5.  Helicobacter felis gastritis in gnotobiotic rats: an animal model of Helicobacter pylori gastritis.

Authors:  J G Fox; A Lee; G Otto; N S Taylor; J C Murphy
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

6.  Attenuation by all-trans-retinoic acid of sodium chloride-enhanced gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.

Authors:  M Tatsuta; H Iishi; M Baba; R Hirasawa; H Yano; N Sakai; A Nakaizumi
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

Review 7.  Multiple genetic alterations in human carcinogenesis.

Authors:  T Sugimura; M Terada; J Yokota; S Hirohashi; K Wakabayashi
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

8.  Inductions of ornithine decarboxylase and DNA synthesis in rat stomach mucosa by formaldehyde.

Authors:  C Furihata; A Yamakoshi; T Matsushima
Journal:  Jpn J Cancer Res       Date:  1988-08

9.  The effects of sodium chloride, miso or ethanol on development of intestinal metaplasia after X-irradiation of the rat glandular stomach.

Authors:  H Watanabe; T Okamoto; T Takahashi; P O Ogundigie; A Ito
Journal:  Jpn J Cancer Res       Date:  1992-12

10.  Synergism between sodium chloride and sodium taurocholate and development of pepsinogen-altered pyloric glands: relevance to a medium-term bioassay system for gastric carcinogens and promoters in rats.

Authors:  M Tatematsu; M Mutai; K Inoue; K Ozaki; C Furihata; N Ito
Journal:  Jpn J Cancer Res       Date:  1989-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.